New strategies to improve drug development in carcinoid tumors (Alliance A021202)
   Google Scholar   
Citation:
Meeting Instance:
NETRF 2020
Year:
2020
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
No-Endpoint
Analysis:
Trial-Description-Only
Status:
Presented/Published
Citation Status:
Note:
Methodological:
No
Biospecimen:
Yes
DataSharing:
No
SDC:
No
Parents:
None
Children:
None
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882, U24CA196171, U10CA180888 (SWOG), U10CA180863 (CCTG),  
Corr. Author:
 
Authors:
                             
Networks:
ADM400, ADM402, ADM403, ALLIANCE, CA136, COLUMBIA, FL065, LAB201, LAB254, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NC010, LAPS-NY016, LAPS-OH007, VA002   
Study
A021202
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
2
Keywords: